Mitchell Mcgill
Concepts (320)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acetaminophen | 62 | 2024 | 282 | 12.140 |
Why?
| Liver | 45 | 2024 | 1109 | 4.600 |
Why?
| Analgesics, Non-Narcotic | 18 | 2024 | 116 | 3.310 |
Why?
| Drug Overdose | 17 | 2024 | 158 | 2.830 |
Why?
| Hepatocytes | 23 | 2024 | 181 | 2.420 |
Why?
| Oxidative Stress | 16 | 2024 | 768 | 1.930 |
Why?
| Liver Failure, Acute | 6 | 2023 | 53 | 1.780 |
Why?
| Alanine Transaminase | 12 | 2023 | 124 | 1.760 |
Why?
| Animals | 66 | 2024 | 13150 | 1.680 |
Why?
| Liver Regeneration | 5 | 2019 | 49 | 1.680 |
Why?
| Mice, Inbred C57BL | 35 | 2022 | 1806 | 1.580 |
Why?
| Glutathione | 14 | 2023 | 295 | 1.430 |
Why?
| Mitochondria, Liver | 8 | 2016 | 70 | 1.370 |
Why?
| Mitochondria | 9 | 2020 | 397 | 1.260 |
Why?
| Mice | 39 | 2024 | 5720 | 1.220 |
Why?
| Cochlea | 2 | 2019 | 19 | 1.210 |
Why?
| JNK Mitogen-Activated Protein Kinases | 12 | 2015 | 72 | 1.190 |
Why?
| End Stage Liver Disease | 2 | 2023 | 44 | 1.040 |
Why?
| DNA, Mitochondrial | 6 | 2017 | 112 | 1.010 |
Why?
| Methamphetamine | 3 | 2022 | 200 | 0.980 |
Why?
| DNA Fragmentation | 5 | 2016 | 55 | 0.970 |
Why?
| Glutamate Dehydrogenase | 5 | 2021 | 16 | 0.930 |
Why?
| Liver Diseases | 2 | 2023 | 76 | 0.910 |
Why?
| Phosphatidic Acids | 2 | 2019 | 8 | 0.790 |
Why?
| Humans | 54 | 2024 | 49827 | 0.780 |
Why?
| Necrosis | 12 | 2020 | 177 | 0.760 |
Why?
| Antioxidants | 4 | 2023 | 248 | 0.750 |
Why?
| Male | 45 | 2022 | 25093 | 0.740 |
Why?
| Plant Extracts | 6 | 2022 | 190 | 0.730 |
Why?
| Disease Models, Animal | 8 | 2019 | 1451 | 0.700 |
Why?
| Xenobiotics | 2 | 2019 | 30 | 0.690 |
Why?
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 2019 | 5 | 0.670 |
Why?
| ortho-Aminobenzoates | 1 | 2019 | 8 | 0.660 |
Why?
| Liver Cirrhosis | 1 | 2021 | 218 | 0.660 |
Why?
| Apoptosis | 9 | 2016 | 1100 | 0.660 |
Why?
| Pharmaceutical Preparations | 1 | 2019 | 76 | 0.640 |
Why?
| Stilbenes | 2 | 2015 | 62 | 0.630 |
Why?
| Phosphatidate Phosphatase | 1 | 2018 | 11 | 0.630 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2014 | 5 | 0.620 |
Why?
| Cytochrome P-450 Enzyme System | 6 | 2020 | 195 | 0.610 |
Why?
| Sulfonamides | 1 | 2019 | 129 | 0.600 |
Why?
| Drug Delivery Systems | 1 | 2019 | 136 | 0.600 |
Why?
| Acetylcysteine | 3 | 2014 | 100 | 0.580 |
Why?
| Reactive Oxygen Species | 5 | 2015 | 408 | 0.580 |
Why?
| Enzyme Inhibitors | 2 | 2019 | 391 | 0.580 |
Why?
| Pyridines | 2 | 2015 | 130 | 0.580 |
Why?
| C-Reactive Protein | 1 | 2018 | 142 | 0.570 |
Why?
| Paraproteins | 1 | 2016 | 12 | 0.560 |
Why?
| Electron Transport Chain Complex Proteins | 2 | 2017 | 9 | 0.550 |
Why?
| Immunoglobulin M | 1 | 2016 | 52 | 0.550 |
Why?
| Nuclear Proteins | 1 | 2018 | 243 | 0.550 |
Why?
| Creatinine | 1 | 2016 | 140 | 0.540 |
Why?
| Ethylmaleimide | 1 | 2015 | 3 | 0.530 |
Why?
| Sulfhydryl Reagents | 1 | 2015 | 3 | 0.530 |
Why?
| Glutathione Reductase | 1 | 2015 | 14 | 0.530 |
Why?
| Hearing | 1 | 2016 | 59 | 0.520 |
Why?
| Signal Transduction | 6 | 2022 | 1617 | 0.520 |
Why?
| DNA | 3 | 2022 | 545 | 0.500 |
Why?
| Furosemide | 1 | 2014 | 10 | 0.500 |
Why?
| Cannabidiol | 3 | 2020 | 37 | 0.490 |
Why?
| Antidotes | 2 | 2014 | 29 | 0.480 |
Why?
| Argininosuccinate Synthase | 1 | 2014 | 1 | 0.480 |
Why?
| Protein Binding | 8 | 2018 | 660 | 0.450 |
Why?
| Carnitine | 1 | 2013 | 62 | 0.440 |
Why?
| Diosgenin | 1 | 2012 | 1 | 0.430 |
Why?
| Dose-Response Relationship, Drug | 11 | 2019 | 1374 | 0.420 |
Why?
| Rats, Wistar | 3 | 2022 | 223 | 0.410 |
Why?
| Prognosis | 5 | 2023 | 1952 | 0.400 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 121 | 0.390 |
Why?
| Critical Illness | 1 | 2013 | 286 | 0.380 |
Why?
| Young Adult | 9 | 2021 | 3936 | 0.370 |
Why?
| Rats | 5 | 2022 | 3300 | 0.360 |
Why?
| Middle Aged | 14 | 2021 | 11997 | 0.350 |
Why?
| Autophagy | 4 | 2021 | 168 | 0.350 |
Why?
| Female | 20 | 2021 | 26329 | 0.340 |
Why?
| Bile Ducts | 2 | 2020 | 46 | 0.340 |
Why?
| Cell Death | 6 | 2020 | 181 | 0.340 |
Why?
| HMGB1 Protein | 3 | 2021 | 17 | 0.340 |
Why?
| Keratin-18 | 3 | 2021 | 15 | 0.340 |
Why?
| Oxidation-Reduction | 2 | 2023 | 319 | 0.330 |
Why?
| Connexins | 3 | 2016 | 25 | 0.300 |
Why?
| Glutathione Disulfide | 3 | 2016 | 41 | 0.290 |
Why?
| Mice, Knockout | 8 | 2018 | 841 | 0.280 |
Why?
| Reperfusion Injury | 2 | 2020 | 87 | 0.280 |
Why?
| Amino Acid Chloromethyl Ketones | 2 | 2016 | 10 | 0.270 |
Why?
| Kinetics | 2 | 2019 | 626 | 0.270 |
Why?
| Adult | 11 | 2021 | 13160 | 0.260 |
Why?
| Hepatitis | 2 | 2016 | 21 | 0.260 |
Why?
| MicroRNAs | 3 | 2020 | 354 | 0.250 |
Why?
| Cholestasis | 2 | 2015 | 40 | 0.250 |
Why?
| Ischemia | 2 | 2016 | 152 | 0.240 |
Why?
| Time Factors | 7 | 2019 | 2912 | 0.240 |
Why?
| Models, Biological | 3 | 2019 | 728 | 0.230 |
Why?
| Alanine | 1 | 2023 | 42 | 0.230 |
Why?
| Pyruvic Acid | 1 | 2023 | 22 | 0.230 |
Why?
| Mitochondrial Proteins | 2 | 2015 | 90 | 0.230 |
Why?
| Lung | 2 | 2019 | 480 | 0.230 |
Why?
| Antipyretics | 2 | 2013 | 3 | 0.220 |
Why?
| Severity of Illness Index | 2 | 2023 | 942 | 0.220 |
Why?
| 5-Methylcytosine | 1 | 2022 | 16 | 0.220 |
Why?
| DNA Damage | 2 | 2014 | 301 | 0.210 |
Why?
| Cannabis | 3 | 2020 | 145 | 0.210 |
Why?
| Cysteine | 2 | 2013 | 49 | 0.210 |
Why?
| Amphetamine | 1 | 2022 | 38 | 0.200 |
Why?
| Half-Life | 1 | 2022 | 84 | 0.200 |
Why?
| Phosphorylation | 3 | 2019 | 536 | 0.200 |
Why?
| Dietary Supplements | 2 | 2022 | 441 | 0.200 |
Why?
| Proliferating Cell Nuclear Antigen | 2 | 2019 | 75 | 0.200 |
Why?
| Tandem Mass Spectrometry | 1 | 2022 | 236 | 0.190 |
Why?
| Risk Assessment | 2 | 2023 | 1262 | 0.190 |
Why?
| Drug Administration Schedule | 1 | 2021 | 376 | 0.180 |
Why?
| Adenosylhomocysteinase | 1 | 2020 | 10 | 0.180 |
Why?
| Alcohol Dehydrogenase | 1 | 2020 | 38 | 0.180 |
Why?
| Aldehyde Dehydrogenase | 1 | 2020 | 26 | 0.180 |
Why?
| Granzymes | 1 | 2020 | 11 | 0.180 |
Why?
| Enzyme Activation | 3 | 2014 | 276 | 0.170 |
Why?
| Biological Transport, Active | 1 | 2019 | 30 | 0.170 |
Why?
| Hepatic Veno-Occlusive Disease | 1 | 2019 | 10 | 0.170 |
Why?
| Aged | 5 | 2018 | 9272 | 0.170 |
Why?
| Sulfotransferases | 1 | 2019 | 40 | 0.170 |
Why?
| Bronchoconstriction | 1 | 2019 | 6 | 0.170 |
Why?
| Anti-Obesity Agents | 1 | 2019 | 19 | 0.170 |
Why?
| Haptoglobins | 1 | 2018 | 4 | 0.170 |
Why?
| Systems Biology | 1 | 2019 | 33 | 0.170 |
Why?
| Pilot Projects | 1 | 2021 | 699 | 0.160 |
Why?
| Anemia, Hemolytic | 1 | 2018 | 11 | 0.160 |
Why?
| Hemolysis | 1 | 2018 | 27 | 0.160 |
Why?
| Aged, 80 and over | 2 | 2018 | 3125 | 0.160 |
Why?
| Tea | 1 | 2019 | 30 | 0.160 |
Why?
| Cell Communication | 1 | 2019 | 69 | 0.160 |
Why?
| Liver Transplantation | 1 | 2020 | 150 | 0.160 |
Why?
| Carbon Tetrachloride | 1 | 2018 | 22 | 0.160 |
Why?
| Myoglobin | 1 | 2018 | 25 | 0.160 |
Why?
| Cells, Cultured | 7 | 2016 | 1571 | 0.160 |
Why?
| Acetylglucosamine | 1 | 2018 | 6 | 0.160 |
Why?
| Anthracenes | 2 | 2014 | 9 | 0.160 |
Why?
| N-Acetylglucosaminyltransferases | 1 | 2018 | 14 | 0.160 |
Why?
| Locomotion | 1 | 2019 | 92 | 0.160 |
Why?
| Glucuronosyltransferase | 1 | 2019 | 126 | 0.160 |
Why?
| Immune Tolerance | 1 | 2018 | 95 | 0.160 |
Why?
| beta Catenin | 1 | 2019 | 102 | 0.160 |
Why?
| Bronchodilator Agents | 1 | 2019 | 73 | 0.150 |
Why?
| Cell Line | 3 | 2015 | 1002 | 0.150 |
Why?
| Hep G2 Cells | 3 | 2015 | 36 | 0.150 |
Why?
| Inflammation | 2 | 2020 | 604 | 0.150 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2018 | 77 | 0.150 |
Why?
| Central Nervous System Stimulants | 1 | 2020 | 213 | 0.150 |
Why?
| Lysosomes | 2 | 2021 | 64 | 0.150 |
Why?
| Dexamethasone | 1 | 2020 | 429 | 0.150 |
Why?
| Genetic Variation | 1 | 2018 | 214 | 0.150 |
Why?
| Bacteria | 1 | 2019 | 223 | 0.150 |
Why?
| Prospective Studies | 2 | 2021 | 2344 | 0.150 |
Why?
| Caspase Inhibitors | 1 | 2016 | 16 | 0.140 |
Why?
| Cell Proliferation | 2 | 2019 | 1007 | 0.140 |
Why?
| Obesity | 2 | 2018 | 1113 | 0.140 |
Why?
| Gene Expression | 1 | 2019 | 608 | 0.140 |
Why?
| Case-Control Studies | 3 | 2014 | 1128 | 0.140 |
Why?
| Kidney Function Tests | 1 | 2016 | 49 | 0.140 |
Why?
| False Positive Reactions | 1 | 2016 | 63 | 0.140 |
Why?
| Drug Evaluation, Preclinical | 2 | 2015 | 144 | 0.140 |
Why?
| Caspases | 1 | 2016 | 104 | 0.140 |
Why?
| Connexin 43 | 1 | 2016 | 25 | 0.130 |
Why?
| Proteomics | 3 | 2022 | 328 | 0.130 |
Why?
| Benzyl Alcohol | 1 | 2015 | 3 | 0.130 |
Why?
| Neutrophils | 2 | 2016 | 137 | 0.130 |
Why?
| Acetanilides | 1 | 2015 | 1 | 0.130 |
Why?
| Analytic Sample Preparation Methods | 1 | 2015 | 4 | 0.130 |
Why?
| Solid Phase Extraction | 1 | 2015 | 12 | 0.130 |
Why?
| Taurocholic Acid | 1 | 2015 | 5 | 0.130 |
Why?
| Prevalence | 1 | 2019 | 943 | 0.130 |
Why?
| Glycochenodeoxycholic Acid | 1 | 2015 | 6 | 0.130 |
Why?
| Species Specificity | 2 | 2015 | 193 | 0.130 |
Why?
| Receptors, Proteinase-Activated | 1 | 2015 | 5 | 0.130 |
Why?
| Protein Stability | 1 | 2015 | 43 | 0.130 |
Why?
| Antithrombin III | 1 | 2015 | 12 | 0.130 |
Why?
| Endonucleases | 1 | 2015 | 15 | 0.130 |
Why?
| Caspase 3 | 2 | 2012 | 97 | 0.130 |
Why?
| Peptide Hydrolases | 1 | 2015 | 62 | 0.120 |
Why?
| Predictive Value of Tests | 2 | 2014 | 904 | 0.120 |
Why?
| Nerve Tissue Proteins | 1 | 2016 | 193 | 0.120 |
Why?
| Glycodeoxycholic Acid | 1 | 2014 | 6 | 0.120 |
Why?
| Blood Proteins | 1 | 2015 | 82 | 0.120 |
Why?
| Body Mass Index | 1 | 2018 | 652 | 0.120 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2016 | 388 | 0.120 |
Why?
| Reactive Nitrogen Species | 2 | 2011 | 22 | 0.120 |
Why?
| Neutrophil Activation | 1 | 2014 | 9 | 0.120 |
Why?
| Up-Regulation | 1 | 2016 | 450 | 0.120 |
Why?
| Aldehyde Oxidase | 1 | 2013 | 1 | 0.120 |
Why?
| Allopurinol | 1 | 2013 | 7 | 0.120 |
Why?
| Gene Expression Regulation | 3 | 2016 | 979 | 0.120 |
Why?
| ROC Curve | 1 | 2014 | 232 | 0.120 |
Why?
| Boron Compounds | 1 | 2013 | 19 | 0.110 |
Why?
| Hematopoietic Stem Cells | 1 | 2015 | 184 | 0.110 |
Why?
| Gap Junctions | 1 | 2013 | 26 | 0.110 |
Why?
| Cohort Studies | 1 | 2018 | 1422 | 0.110 |
Why?
| Receptors, Formyl Peptide | 1 | 2013 | 4 | 0.110 |
Why?
| Acute-Phase Reaction | 1 | 2013 | 8 | 0.110 |
Why?
| Sex Characteristics | 1 | 2014 | 190 | 0.110 |
Why?
| Blood Platelets | 1 | 2015 | 245 | 0.110 |
Why?
| Cathepsin B | 1 | 2012 | 5 | 0.110 |
Why?
| Phytotherapy | 1 | 2013 | 44 | 0.110 |
Why?
| Purinergic P2X Receptor Antagonists | 1 | 2012 | 4 | 0.110 |
Why?
| Chemokines | 1 | 2013 | 77 | 0.110 |
Why?
| MAP Kinase Kinase 4 | 1 | 2012 | 29 | 0.110 |
Why?
| Metabolomics | 1 | 2013 | 124 | 0.100 |
Why?
| Tetrazoles | 1 | 2012 | 41 | 0.100 |
Why?
| Glutathione Transferase | 1 | 2013 | 174 | 0.100 |
Why?
| Rats, Inbred F344 | 1 | 2012 | 196 | 0.100 |
Why?
| NF-E2-Related Factor 2 | 1 | 2012 | 41 | 0.100 |
Why?
| Reproducibility of Results | 1 | 2015 | 1188 | 0.100 |
Why?
| Models, Theoretical | 1 | 2013 | 174 | 0.100 |
Why?
| Microtubule-Associated Proteins | 1 | 2012 | 67 | 0.100 |
Why?
| Survival Rate | 1 | 2014 | 905 | 0.100 |
Why?
| Liver Function Tests | 3 | 2019 | 46 | 0.100 |
Why?
| Kidney | 1 | 2015 | 665 | 0.100 |
Why?
| Gentiana | 1 | 2010 | 1 | 0.090 |
Why?
| Ligation | 2 | 2020 | 59 | 0.090 |
Why?
| Adolescent | 3 | 2016 | 6340 | 0.080 |
Why?
| L-Lactate Dehydrogenase | 2 | 2022 | 65 | 0.080 |
Why?
| Chaperonin 60 | 1 | 2008 | 5 | 0.080 |
Why?
| Mice, Inbred Strains | 2 | 2019 | 161 | 0.080 |
Why?
| Computer Simulation | 2 | 2020 | 282 | 0.080 |
Why?
| Rats, Sprague-Dawley | 1 | 2012 | 1595 | 0.080 |
Why?
| Recombinant Fusion Proteins | 1 | 2008 | 182 | 0.080 |
Why?
| Cell Line, Tumor | 1 | 2011 | 1402 | 0.070 |
Why?
| Cytochrome P-450 CYP2E1 | 2 | 2020 | 113 | 0.070 |
Why?
| Primary Cell Culture | 2 | 2015 | 61 | 0.060 |
Why?
| Peroxynitrous Acid | 2 | 2015 | 32 | 0.060 |
Why?
| Cyclosporine | 2 | 2015 | 64 | 0.060 |
Why?
| Cytokines | 2 | 2016 | 612 | 0.050 |
Why?
| Methylation | 1 | 2022 | 123 | 0.050 |
Why?
| Plant Preparations | 1 | 2022 | 37 | 0.050 |
Why?
| Vitamins | 1 | 2022 | 64 | 0.050 |
Why?
| Interleukin-10 | 1 | 2022 | 84 | 0.050 |
Why?
| Ligands | 1 | 2022 | 204 | 0.050 |
Why?
| Chromatography, Liquid | 1 | 2022 | 232 | 0.050 |
Why?
| Cytoprotection | 2 | 2012 | 35 | 0.050 |
Why?
| Anti-Inflammatory Agents | 1 | 2022 | 162 | 0.050 |
Why?
| Biological Assay | 1 | 2021 | 45 | 0.050 |
Why?
| Taurine | 1 | 2020 | 15 | 0.050 |
Why?
| Interleukin-6 | 1 | 2022 | 264 | 0.050 |
Why?
| Acyltransferases | 1 | 2020 | 29 | 0.050 |
Why?
| Herb-Drug Interactions | 1 | 2020 | 30 | 0.050 |
Why?
| Toxicity Tests | 1 | 2020 | 52 | 0.050 |
Why?
| Alkaline Phosphatase | 1 | 2020 | 94 | 0.050 |
Why?
| Monte Carlo Method | 1 | 2020 | 84 | 0.040 |
Why?
| Cytochrome P-450 CYP1A2 | 1 | 2020 | 39 | 0.040 |
Why?
| Glutamine | 1 | 2020 | 171 | 0.040 |
Why?
| Cytochrome P-450 CYP3A | 1 | 2020 | 78 | 0.040 |
Why?
| Carbachol | 1 | 2019 | 27 | 0.040 |
Why?
| Hepatectomy | 1 | 2019 | 29 | 0.040 |
Why?
| Respiratory Hypersensitivity | 1 | 2019 | 17 | 0.040 |
Why?
| Drug Synergism | 1 | 2019 | 150 | 0.040 |
Why?
| Thinness | 1 | 2019 | 46 | 0.040 |
Why?
| Organ Culture Techniques | 1 | 2019 | 50 | 0.040 |
Why?
| Computational Biology | 1 | 2020 | 214 | 0.040 |
Why?
| Acylation | 1 | 2018 | 7 | 0.040 |
Why?
| Albuterol | 1 | 2019 | 54 | 0.040 |
Why?
| Software | 1 | 2020 | 273 | 0.040 |
Why?
| Galactosamine | 1 | 2016 | 4 | 0.040 |
Why?
| Transcriptome | 1 | 2019 | 313 | 0.040 |
Why?
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 6 | 0.030 |
Why?
| Injections, Intraperitoneal | 1 | 2015 | 54 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 2016 | 303 | 0.030 |
Why?
| Linear Models | 1 | 2016 | 281 | 0.030 |
Why?
| Protective Agents | 1 | 2015 | 14 | 0.030 |
Why?
| Apoptosis Inducing Factor | 1 | 2015 | 4 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2016 | 191 | 0.030 |
Why?
| Immunoenzyme Techniques | 1 | 2015 | 143 | 0.030 |
Why?
| Fatty Acids | 1 | 2015 | 143 | 0.030 |
Why?
| Anesthetics, Local | 1 | 2015 | 75 | 0.030 |
Why?
| Blood Coagulation | 1 | 2015 | 57 | 0.030 |
Why?
| Bile Acids and Salts | 1 | 2015 | 75 | 0.030 |
Why?
| Asthma | 1 | 2019 | 283 | 0.030 |
Why?
| Tyrosine | 1 | 2015 | 95 | 0.030 |
Why?
| NF-kappa B | 1 | 2016 | 314 | 0.030 |
Why?
| Poisoning | 1 | 2014 | 24 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2015 | 119 | 0.030 |
Why?
| Subcellular Fractions | 1 | 2014 | 34 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 181 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2014 | 89 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2019 | 1031 | 0.030 |
Why?
| Oxypurinol | 1 | 2013 | 1 | 0.030 |
Why?
| Granulocytes | 1 | 2014 | 27 | 0.030 |
Why?
| Metallothionein | 1 | 2013 | 9 | 0.030 |
Why?
| Xanthine Oxidase | 1 | 2013 | 14 | 0.030 |
Why?
| Blotting, Western | 1 | 2015 | 602 | 0.030 |
Why?
| tert-Butylhydroperoxide | 1 | 2013 | 5 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2013 | 81 | 0.030 |
Why?
| Dimethyl Sulfoxide | 1 | 2013 | 12 | 0.030 |
Why?
| Mitochondrial Diseases | 1 | 2014 | 42 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 181 | 0.030 |
Why?
| Ketones | 1 | 2012 | 9 | 0.030 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2012 | 22 | 0.030 |
Why?
| Dipeptides | 1 | 2012 | 21 | 0.030 |
Why?
| 3-Hydroxybutyric Acid | 1 | 2012 | 2 | 0.030 |
Why?
| RNA, Messenger | 1 | 2016 | 1105 | 0.030 |
Why?
| Hepatomegaly | 1 | 2012 | 7 | 0.030 |
Why?
| Sulfates | 1 | 2012 | 25 | 0.030 |
Why?
| Glucuronides | 1 | 2012 | 45 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2012 | 96 | 0.030 |
Why?
| Oxidants | 1 | 2012 | 53 | 0.030 |
Why?
| Inflammasomes | 1 | 2012 | 58 | 0.030 |
Why?
| Lactic Acid | 1 | 2012 | 76 | 0.020 |
Why?
| Proteins | 1 | 2014 | 341 | 0.020 |
Why?
| Triglycerides | 1 | 2012 | 159 | 0.020 |
Why?
| Amiodarone | 1 | 2011 | 22 | 0.020 |
Why?
| Fatty Liver | 1 | 2012 | 127 | 0.020 |
Why?
| Carrier Proteins | 1 | 2012 | 304 | 0.020 |
Why?
| Lipid Peroxidation | 1 | 2011 | 100 | 0.020 |
Why?
| Cell Survival | 1 | 2012 | 598 | 0.020 |
Why?
| Immunity, Innate | 1 | 2011 | 104 | 0.020 |
Why?
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2008 | 1 | 0.020 |
Why?
| Chaperonins | 1 | 2008 | 3 | 0.020 |
Why?
| Protein Folding | 1 | 2008 | 49 | 0.020 |
Why?
| Protein Conformation | 1 | 2008 | 166 | 0.020 |
Why?
| Binding Sites | 1 | 2008 | 377 | 0.020 |
Why?
| Models, Molecular | 1 | 2008 | 337 | 0.020 |
Why?
| Child | 1 | 2020 | 6824 | 0.020 |
Why?
| United States | 1 | 2016 | 4838 | 0.020 |
Why?
|
|
Mcgill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|